We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Immune Responsive Nanoparticles for COVID-19 Vaccine Delivery

Product News   Jun 04, 2020

 
Immune Responsive Nanoparticles for COVID-19 Vaccine Delivery
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

TALLC Granted UK Patent for SmartCelle Ocular Drug Delivery Technology

Product News

TALLC has announced that the United Kingdom Intellectual Property Office (IPO) has granted the first in a series of SmartCelle smart micelle patents covering their novel nanotechnology for ocular drug delivery.

READ MORE

Intravacc to In-license CimCure’s iBoost Technology

Product News

Intravacc has announced the signing of a strategic partnership agreement with Dutch-based CimCure for in-licensing CimCure’s iBoost technology.

READ MORE

Kerafast Offers the Delta-G-VSV Pseudotyping System for Coronavirus Research

Product News

Kerafast Inc. has announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications, enabling studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 containment.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE